ACSL3

acyl-CoA synthetase long chain family member 3, the group of Acyl-CoA synthetase family

Basic information

Region (hg38): 2:222860942-222944639

Previous symbols: [ "FACL3" ]

Links

ENSG00000123983NCBI:2181OMIM:602371HGNC:3570Uniprot:O95573AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ACSL3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSL3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
2
clinvar
3
missense
17
clinvar
2
clinvar
19
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 17 3 2

Variants in ACSL3

This is a list of pathogenic ClinVar variants found in the ACSL3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-222908805-C-T Benign/Likely benign (Mar 01, 2023)712051
2-222908851-C-T not specified Uncertain significance (Jun 16, 2023)2603871
2-222908870-A-G not specified Uncertain significance (Mar 20, 2023)2508745
2-222908890-C-G not specified Uncertain significance (Aug 12, 2021)2243533
2-222916424-A-G not specified Uncertain significance (Oct 25, 2023)3139949
2-222916427-G-T not specified Uncertain significance (Aug 01, 2022)2401103
2-222916430-A-G not specified Uncertain significance (Mar 19, 2024)3262845
2-222916468-A-G Benign (May 04, 2018)777142
2-222919158-A-T not specified Uncertain significance (May 01, 2024)3262851
2-222919191-A-G Likely benign (May 30, 2018)724724
2-222919199-A-G not specified Likely benign (Jun 27, 2023)2594647
2-222921325-T-C not specified Uncertain significance (May 26, 2022)2291225
2-222922760-A-G not specified Uncertain significance (Dec 01, 2022)2223715
2-222922811-C-T not specified Uncertain significance (Feb 22, 2023)2468427
2-222922829-C-G not specified Uncertain significance (Dec 15, 2022)2335063
2-222922830-A-G not specified Uncertain significance (Nov 08, 2022)2283776
2-222923079-C-A not specified Uncertain significance (May 30, 2023)2552587
2-222927019-T-C not specified Uncertain significance (Jan 04, 2022)2269087
2-222927027-C-T not specified Uncertain significance (Dec 07, 2021)2265903
2-222927117-A-G not specified Uncertain significance (Aug 02, 2021)2363799
2-222930750-A-G not specified Uncertain significance (Nov 15, 2021)2213509
2-222933168-C-G not specified Uncertain significance (Oct 03, 2022)2314858
2-222934531-T-C not specified Uncertain significance (Nov 12, 2021)2260584
2-222934572-G-A Benign (Aug 24, 2018)714170

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ACSL3protein_codingprotein_codingENST00000357430 1483706
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0003481.001257310171257480.0000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.012833960.7150.00002114711
Missense in Polyphen97176.490.54962050
Synonymous-0.9601541401.100.000007551377
Loss of Function3.721337.60.3460.00000204468

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005900.0000590
Ashkenazi Jewish0.000.00
East Asian0.0001100.000109
Finnish0.0001390.000139
European (Non-Finnish)0.00008820.0000879
Middle Eastern0.0001100.000109
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acyl-CoA synthetases (ACSL) activates long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL3 mediates hepatic lipogenesis (By similarity). Preferentially uses myristate, laurate, arachidonate and eicosapentaenoate as substrates (By similarity). Has mainly an anabolic role in energy metabolism. Required for the incorporation of fatty acids into phosphatidylcholine, the major phospholipid located on the surface of VLDL (very low density lipoproteins). {ECO:0000250, ECO:0000269|PubMed:18003621}.;
Pathway
Adipocytokine signaling pathway - Homo sapiens (human);Peroxisome - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);Fatty acid biosynthesis - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Fatty Acid Beta Oxidation;Fatty Acid Biosynthesis;Mitochondrial LC-Fatty Acid Beta-Oxidation;PPAR signaling pathway;Liver steatosis AOP;stearate biosynthesis;Metabolism of lipids;Fatty acyl-CoA biosynthesis;fatty acid activation;Leukotriene metabolism;Omega-3 fatty acid metabolism;Metabolism;Fatty acid metabolism;γ-linolenate biosynthesis;Mono-unsaturated fatty acid beta-oxidation;Omega-6 fatty acid metabolism;Di-unsaturated fatty acid beta-oxidation;Phytanic acid peroxisomal oxidation;fatty acid β-oxidation (peroxisome);icosapentaenoate biosynthesis II (metazoa);fatty acid β-oxidation;Synthesis of very long-chain fatty acyl-CoAs (Consensus)

Recessive Scores

pRec
0.186

Intolerance Scores

loftool
0.500
rvis_EVS
0.13
rvis_percentile_EVS
63.49

Haploinsufficiency Scores

pHI
0.827
hipred
Y
hipred_score
0.554
ghis
0.512

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.997

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Acsl3
Phenotype
growth/size/body region phenotype; immune system phenotype; hematopoietic system phenotype;

Gene ontology

Biological process
long-chain fatty acid metabolic process;fatty acid biosynthetic process;brain development;response to nutrient;response to organic cyclic compound;very-low-density lipoprotein particle assembly;long-chain fatty-acyl-CoA biosynthetic process;positive regulation of Golgi to plasma membrane protein transport;long-chain fatty acid import;positive regulation of secretion;positive regulation of phosphatidylcholine biosynthetic process
Cellular component
mitochondrial outer membrane;peroxisomal membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;lipid droplet;membrane;integral component of membrane;perinuclear region of cytoplasm
Molecular function
long-chain fatty acid-CoA ligase activity;ATP binding;protein kinase binding;protein domain specific binding;decanoate-CoA ligase activity